Please join us for the ACC Rockies Chapter Meeting from September 8-9, 2023 at the Hyatt Centric in Park City, Utah. For more information and to register, please visit:
https://web.cvent.com/event/314c67f2-d26f-4ad9-bfd7-8011b1bd9dcb/summary
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- AI-Derived Risk Score for Mortality in Secondary Mitral RegurgitationWhat is the performance of an artificial intelligence (AI)-derived risk score in predicting 1-year outcomes of patients with secondary mitral regurgitation (SMR) undergoing transcatheter edge-to-edge repair (TEER)?
- Donor Heart Acceptance by Race and Gender on Transplant WaitlistFor patients on the heart transplant waiting list, what association does race and gender have with the probability of donor heart offers being accepted?
- Secondary Mitral Regurgitation Phenotypes and M-TEER Trials: Key PointsThe following are key points to remember from a state-of-the-art review on the evolving concept of secondary mitral regurgitation (MR) phenotypes and lessons from the mitral transcatheter edge-to-edge repair (M-TEER) trials.
- Risk of Dementia During Antihypertensive Drug TherapyWhat is the effect of antihypertensive drug treatment on the risk of dementia or Alzheimer’s disease among new users of antihypertensive medications?
- Eagle’s Eye View: Sacubitril/Valsartan in Decompensated Heart Failure; Discordant Aortic Stenosis and Transcatheter Treatment of Tricuspid Valve RegurgitationIn this week’s View, Dr. Eagle looks at sacubitril/valsartan in patients hospitalized with decompensated heart failure, then examines the prevalence and outcomes of patients with discordant high gradient aortic stenosis.